Emerging From the Haze™- Measuring the Impact of a Psycho-education Program on Perceived Cognition After Breast Cancer Treatment

Inclusion Criteria: * Completed treatment for stage 1-3 breast cancer at least two months but not more than 24 months prior to enrollment. * Having received chemotherapy with or without radiation therapy * Female, Age ≥18 years. * FACT-Cog score less than 59 on the Perceived Cognitive Impairment subscale * Eligible after 2 months of completing all their active cancer treatment with the exception of long-term hormonal treatments or trastuzumab. * Subjective complaint of cognitive concerns at time of enrollment * Must be able to understand and communicate proficiently in English * Ability to understand and the willingness to sign a written informed consent. * Agree to complete study surveys Exclusion Criteria: * Patients who have significant personality disorders or unstable psychiatric disorders (including active major depression, substance abuse, psychosis or bipolar disorder) as assessed by the interviewing clinician * Patients with known brain metastases, history of brain metastases or radiation to the brain. * Patients with a history of stroke or other pre-existing neurological condition that may contribute to cognitive dysfunction. * Non-English speakers * Receiving treatment for another malignancy other than breast cancer * Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, chronic anemia, uncontrolled hypothyroidism, symptomatic congestive heart failure, unstable angina pectoris, uncontrolled cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.